Avanos Medical, Inc. (NYSE: AVNS) is a medical technology company focused on delivering clinical medical device solutions. The company consists of two franchises – Pain Management and Chronic Care – that address reducing the use of opioids while helping patients recover faster and preventing infection.
Avanos sells its brands and products in more than 90 countries and operates 8 principal medical device production facilities with 4,500 employees worldwide – generating approximately $612 million in net revenue.Avanos Medical, Inc., is traded on the New York Stock Exchange under the ticker symbol “AVNS”.
Index: NYSE; Sector: Healthcare; Industry: Medical Equipment & Supplies;
Marketcap: 1.62B; Volume: 22.36K; AvgVol 3m: 249.81K; Beta: –;
P/E: –; EPS: -0.35; EPS growth quarter/prev quarter: 62.70%;
EPS growth this year: -267.10%; EPS growth past 5 years: -29.60%;
EPS ttm: -0.36;
P/S: 2.46; P/B: 1.39; P/Cashflow: 9.39; P/FCF: ;
Sales: 705.30M; Sales growth quarter/prev quarter: -4.90%; Sales growth past 5 years: -16.00%;
Gross Margin: 55.80%; Profit Margin: -2.40%; Operating Margin: -3.20%;
ROA – return on assets: -0.90%; ROE – return on equity: -1.30%; LT Debt/Equity: 0.20; Total Debt/Equity: 0.20;
Dividend: –; Dividend Yield (%): –;
Insider Ownership: 0.70%; Insider Transactions:3.10%;
Institutional Ownership: 98.00%; Institutional Transactions: 1.65%;
Data update: 07/10/2020.